Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Clinical characteristics and management of acute stroke in patients with atrial fibrillation admitted to US university hospitals.
Neurology. 1997 Jun;48(6):1598-604. doi: 10.1212/wnl.48.6.1598.
Neurology. 1997.
PMID: 9191773
Status of antithrombotic therapy for patients with atrial fibrillation in university hospitals.
Albers GW, Yim JM, Belew KM, Bittar N, Hattemer CR, Phillips BG, Kemp S, Hall EA, Morton DJ, Vlasses PH.
Albers GW, et al. Among authors: hattemer cr.
Arch Intern Med. 1996 Nov 11;156(20):2311-6.
Arch Intern Med. 1996.
PMID: 8911237
Item in Clipboard
Coronary perforation during percutaneous coronary intervention in the era of abciximab platelet glycoprotein IIb/IIIa blockade: an algorithm for percutaneous management.
Dippel EJ, Kereiakes DJ, Tramuta DA, Broderick TM, Shimshak TM, Roth EM, Hattemer CR, Runyon JP, Whang DD, Schneider JF, Abbottsmith CW.
Dippel EJ, et al. Among authors: hattemer cr.
Catheter Cardiovasc Interv. 2001 Mar;52(3):279-86. doi: 10.1002/ccd.1065.
Catheter Cardiovasc Interv. 2001.
PMID: 11246236
Item in Clipboard
A rapid diagnostic and treatment center for patients with chest pain in the emergency department.
Gibler WB, Runyon JP, Levy RC, Sayre MR, Kacich R, Hattemer CR, Hamilton C, Gerlach JW, Walsh RA.
Gibler WB, et al. Among authors: hattemer cr.
Ann Emerg Med. 1995 Jan;25(1):1-8. doi: 10.1016/s0196-0644(95)70347-0.
Ann Emerg Med. 1995.
PMID: 7802357
Item in Clipboard
Abciximab provides cost-effective survival advantage in high-volume interventional practice.
Kereiakes DJ, Obenchain RL, Barber BL, Smith A, McDonald M, Broderick TM, Runyon JP, Shimshak TM, Schneider JF, Hattemer CR, Roth EM, Whang DD, Cocks D, Abbottsmith CW.
Kereiakes DJ, et al. Among authors: hattemer cr.
Am Heart J. 2000 Oct;140(4):603-10. doi: 10.1067/mhj.2000.109647.
Am Heart J. 2000.
PMID: 11011333
Item in Clipboard
Time course, magnitude, and consistency of platelet inhibition by abciximab, tirofiban, or eptifibatide in patients with unstable angina pectoris undergoing percutaneous coronary intervention.
Kereiakes DJ, Broderick TM, Roth EM, Whang D, Shimshak T, Runyon JP, Hattemer C, Schneider J, Lacock P, Mueller M, Abbottsmith CW.
Kereiakes DJ, et al.
Am J Cardiol. 1999 Aug 15;84(4):391-5. doi: 10.1016/s0002-9149(99)00321-5.
Am J Cardiol. 1999.
PMID: 10468074
Clinical Trial.
Item in Clipboard
Ergonovine-testing-directed therapy and long-term outcome of sudden-death survivors with no apparent heart disease.
Ritchie ME, Hattemer C, Lenihan D.
Ritchie ME, et al.
Cardiology. 1998;89(1):76-8. doi: 10.1159/000006747.
Cardiology. 1998.
PMID: 9452162
Item in Clipboard
Cite
Cite